Interaction of the fanconi anemia proteins and BRCA1 in a common pathway

被引:953
作者
Garcia-Higuera, I
Taniguchi, T
Ganesan, S
Meyn, MS
Timmers, C
Hejna, J
Grompe, M
D'Andrea, AD [1 ]
机构
[1] Harvard Univ, Sch Med, Childrens Hosp, Dana Farber Canc Inst,Dept Pediat Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Childrens Hosp, Dept Pediat, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Oncol, Boston, MA 02115 USA
[4] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[5] Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA
[6] Oregon Hlth Sci Univ, Dept Pediat, Portland, OR 97201 USA
关键词
D O I
10.1016/S1097-2765(01)00173-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fanconi anemia (FA) is a human autosomal recessive cancer susceptibility disorder characterized by cellular sensitivity to mitomycin C and ionizing radiation. Although six FA genes (for subtypes A, C, D2, E, F, and G) have been cloned, their relationship to DNA repair remains unknown. In the current study, we show that a nuclear complex containing the FANCA, FANCC, FANCF, and FANCG proteins is required for the activation of the FANCD2 protein to a monoubiquitinated isoform. In normal (non-FA) cells, FANCD2 is monoubiquitinated in response to DNA damage and is targeted to nuclear foci (dots). Activated FANCD2 protein colocalizes with the breast cancer susceptibility protein, BRCA1, in ionizing radiation-induced foci and in synaptonemal complexes of meiotic chromosomes. The FANCD2 protein, therefore, provides the missing link between the FA protein complex and the cellular BRCA1 repair machinery. Disruption of this pathway results in the cellular and clinical phenotype common to all FA subtypes.
引用
收藏
页码:249 / 262
页数:14
相关论文
共 68 条
  • [1] Alter BP, 1996, AM J HEMATOL, V53, P99, DOI 10.1002/(SICI)1096-8652(199610)53:2<99::AID-AJH7>3.0.CO
  • [2] 2-Z
  • [3] Positional cloning of the Fanconi anaemia group A gene
    Apostolou, S
    Whitmore, SA
    Crawford, J
    Lennon, G
    Sutherland, GR
    Callen, DF
    Ianzano, L
    Savino, M
    DApolito, M
    Notarangelo, A
    Memeo, E
    Piemontese, MR
    Zelante, L
    Savoia, A
    Gibson, RA
    Tipping, AJ
    Morgan, NV
    Hassock, S
    Jansen, S
    deRavel, TJ
    VanBerkel, C
    Pronk, JC
    Easton, DF
    Mathew, CG
    Levran, O
    Verlander, PC
    Batish, SD
    Erlich, T
    Auerbach, AD
    CletonJansen, AM
    Moerland, EW
    Cornelisse, CJ
    Doggett, NA
    Deaven, LL
    Moyzis, RK
    [J]. NATURE GENETICS, 1996, 14 (03) : 324 - 328
  • [4] AUERBACH AD, 1993, EXP HEMATOL, V21, P731
  • [5] THE RNA POLYMERASE-I TRANSCRIPTION FACTOR XUBF CONTAINS 5 TANDEMLY REPEATED HMG HOMOLOGY BOXES
    BACHVAROV, D
    MOSS, T
    [J]. NUCLEIC ACIDS RESEARCH, 1991, 19 (09) : 2331 - 2335
  • [6] STUDIES OF MALFORMATION SYNDROMES OF MAN .47. DISAPPEARANCE OF SPERMATOGONIA IN FANCONI ANEMIA SYNDROME
    BARGMAN, GJ
    SHAHIDI, NT
    GILBERT, EF
    OPITZ, JM
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1977, 125 (03) : 163 - 168
  • [7] G2 CHROMOSOMAL RADIOSENSITIVITY IN FANCONIS ANEMIA
    BIGELOW, SB
    RARY, JM
    BENDER, MA
    [J]. MUTATION RESEARCH, 1979, 63 (01): : 189 - 199
  • [8] Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups
    Carreau, M
    Alon, N
    Bosnoyan-Collins, L
    Joenje, H
    Buchwald, M
    [J]. MUTATION RESEARCH-DNA REPAIR, 1999, 435 (01): : 103 - 109
  • [9] Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia
    Chen, M
    Tomkins, DJ
    Auerbach, W
    McKerlie, C
    Youssoufian, H
    Liu, L
    Gan, O
    Carreau, M
    Auerbach, A
    Groves, T
    Guidos, CJ
    Freedman, MH
    Cross, J
    Percy, DH
    Dick, JE
    Joyner, AL
    Buchwald, M
    [J]. NATURE GENETICS, 1996, 12 (04) : 448 - 451
  • [10] THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY
    CIECHANOVER, A
    [J]. CELL, 1994, 79 (01) : 13 - 21